Biogen Idec

George A. Scangos, Ph.D. has been appointed chief executive officer of Biogen Idec, effective July 15. He will also be named to the board of directors. Dr. Scangos has 25 years of experience in the biotechnology and pharmaceutical industries. He joins the company from Exelixis, Inc. where he has served as president and chief executive officer since 1996. Under Dr. Scangos’ leadership, Exelixis advanced a pipeline of 14 clinical compounds and forged numerous strategic partnerships.

Previously, Dr. Scangos spent 10 years at Bayer Corp. He joined the company as a staff scientist, and later served as president of Bayer Biotechnology, where he was responsible for research, business development, process development, manufacturing, engineering, and quality assurance of Bayer’s biological products. Before joining Bayer, Dr. Scangos was a Professor of Biology at Johns Hopkins University for six years.